Law360 (November 9, 2006, 12:00 AM EST) -- U.S. and Korean negotiators are struggling to bridge their differences in talks to amend South Korea’s regulatory regime for patented drugs, according to sources close to the negotiations.
The talks, part...
Pharma Stalls U.S., Korean Free Trade Talks
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
